Carter Eric G

USNatural personDirector

Insider

Carter Eric G

USNatural personDirector

Transactions

Issuers

Buys / Sells

0/0

Last tx

21 May 2025

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
AEON Biopharma, Inc.	308,641	reported	21 May 2025	tx 8+544,922
ALDER BIOPHARMACEUTICALS INC	75,000	reported	23 Apr 2018	tx 1+75,000
Avalanche Biotechnologies, Inc.	30,000	reported	23 Jun 2020	tx 5+227,000
KING PHARMACEUTICALS INC	0	reported	31 Jan 2011	tx 34+505,206−476,551

Recent transactions

Date	Type	Issuer	Qty	Signals
21 May 2025	GRANT_AWARD	AEON Biopharma, Inc.	308,641	deriv
31 Aug 2024	GRANT_AWARD	AEON Biopharma, Inc.	36,021
31 Aug 2024	GRANT_AWARD	AEON Biopharma, Inc.	96,210	deriv
19 Mar 2024	GRANT_AWARD	AEON Biopharma, Inc.	16,260

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
AEON Biopharma, Inc.	308,641	reported	21 May 2025	tx 8+544,922
ALDER BIOPHARMACEUTICALS INC	75,000	reported	23 Apr 2018	tx 1+75,000
Avalanche Biotechnologies, Inc.	30,000	reported	23 Jun 2020	tx 5+227,000
KING PHARMACEUTICALS INC	0	reported	31 Jan 2011	tx 34+505,206−476,551

Recent transactions

Date	Type	Issuer	Qty	Signals
21 May 2025	GRANT_AWARD	AEON Biopharma, Inc.	308,641	deriv
31 Aug 2024	GRANT_AWARD	AEON Biopharma, Inc.	36,021
31 Aug 2024	GRANT_AWARD	AEON Biopharma, Inc.	96,210	deriv
19 Mar 2024	GRANT_AWARD	AEON Biopharma, Inc.	16,260